Free Trial

Merck KGaA (OTCMKTS:MKKGY) Sees Unusually-High Trading Volume Following Better-Than-Expected Earnings

Merck KGaA logo with Medical background

Key Points

  • Merck KGaA shares experienced a significant increase in trading volume, up 285% from the previous session, after reporting better-than-expected quarterly earnings.
  • The company's earnings per share for the quarter was $0.57, surpassing the consensus estimate of $0.51, with revenues reaching $6.11 billion against expectations of $5.34 billion.
  • Merck KGaA's current stock price is $25.47, and it has a market capitalization of $16.42 billion with a P/E ratio of 12.03.
  • Want stock alerts on Merck KGaA? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Merck KGaA (OTCMKTS:MKKGY - Get Free Report) shares saw an uptick in trading volume on Friday following a stronger than expected earnings report. 546,189 shares traded hands during trading, an increase of 285% from the previous session's volume of 142,039 shares.The stock last traded at $25.47 and had previously closed at $24.54.

The company reported $0.57 EPS for the quarter, beating the consensus estimate of $0.51 by $0.06. The company had revenue of $6.11 billion for the quarter, compared to analyst estimates of $5.34 billion. Merck KGaA had a return on equity of 9.81% and a net margin of 13.49%.

Merck KGaA Stock Down 0.1%

The firm has a market capitalization of $16.86 billion, a price-to-earnings ratio of 10.96, a P/E/G ratio of 3.10 and a beta of 0.91. The stock has a 50 day moving average of $25.94 and a 200 day moving average of $27.18. The company has a quick ratio of 0.83, a current ratio of 1.31 and a debt-to-equity ratio of 0.23.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Featured Stories

Should You Invest $1,000 in Merck KGaA Right Now?

Before you consider Merck KGaA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.

While Merck KGaA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines